Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MNX1
REST API REST API
Homo sapiens
MNX1 is differentially expressed in 193 experiments: 66 organism parts: pancreas, amygdala, ... (64 more);, 142 disease states: normal, colon carcinoma, ... (140 more);, 46 cell types 388 cell lines 12 compound treatments and 53 other conditions.
Synonyms HLXB9, SCRA1, HOXHB9, HB9
Orthologs mnx1 (Danio rerio)   F1P1C8_CHICK (Gallus gallus)   Mnx1 (Mus musculus)   F6U2P7_CIOIN (Ciona intestinalis)   MNX1 (Bos taurus)   exex (Drosophila melanogaster)   mnx1 (Xenopus laevis)   MNX1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term neuron differentiation, humoral immune response, regulation of transcription, DNA-dependent, transcription, DNA-dependent, cell morphogenesis involved in neuron differentiation, motor axon guidance, sequence-specific DNA binding, anatomical structure morphogenesis, nucleus, post-embryonic development, neuron projection morphogenesis, regulation of transcription from RNA polymerase II promoter, neuron migration, central nervous system neuron differentiation, diaphragm development, dorsal/ventral neural tube patterning, pancreas development, respiratory system development, spinal cord motor neuron cell fate specification, endocrine pancreas development, nerve development, sequence-specific DNA binding transcription factor activity
InterPro Term Homeobox, Homeobox_eu
Gene-Disease Assocation CURRARINO SYNDROME
UniProt Accession P50219, C9JFT4, C9K088, F5H401
Search EB-eye ENSG00000130675
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-803, E-MTAB-24, E-MEXP-433, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (40 experiments)

Factor Value U/D Experiments
LNCaP
3
E-GEOD-14464, E-GEOD-847, E-GEOD-14990
CCRFCEM
2
E-MTAB-37, E-GEOD-24147
HT1080
2
E-MTAB-37, E-GEOD-20089
MCF-7
2
E-GEOD-20081, E-GEOD-19639
SW480
2
E-MEXP-1014, E-MTAB-37
HL-60
1
2
E-GEOD-5258, E-MTAB-37, E-GEOD-24147
382 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-3920, E-GEOD-20677, E-GEOD-13909, E-GEOD-13987, ... (30 experiments)

Factor Value U/D Experiments
macrophage
2
E-GEOD-22373, E-GEOD-3982
mononuclear cell
1
E-GEOD-6053
native fetal RPE
1
E-GEOD-18811
white blood cell
1
E-GEOD-2006
embryonic stem cell
1
E-MEXP-930
immortalised T lymphocytes
1
E-GEOD-13909
40 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-4045, E-TABM-15, E-MEXP-121, E-GEOD-20602, ... (36 experiments)

Factor Value U/D Experiments
colorectal carcinoma
3
E-MTAB-37, E-GEOD-23878, E-GEOD-4045
colon carcinoma
3
E-MTAB-37, E-GEOD-3726, E-MTAB-62
lung adenocarcinoma
2
E-MTAB-62, E-GEOD-2514
prostate carcinoma
1
2
E-MEXP-1327, E-MTAB-62, E-MEXP-2034
superficial transitional cell carcinoma without surrounding carcinoma in situ lesion
1
E-GEOD-3167
T cell lymphoblast-like cell line
1
E-MTAB-62
136 more value(s).


Compound treatment

studied in E-GEOD-20719, E-GEOD-6907, E-GEOD-412, E-TABM-782, E-GEOD-5824, ... (9 experiments)

Factor Value U/D Experiments
none
1
3
E-GEOD-5824, E-GEOD-412, E-TABM-782, E-GEOD-20719
actinomycin D
1
1
E-GEOD-6400
Cxcl12
1
E-GEOD-7307
not specified
1
E-GEOD-20081
rapamycin
1
E-GEOD-5824
hydrogen peroxide
2
1
E-GEOD-5339
6 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, E-GEOD-21340 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-2191, E-GEOD-21589, E-GEOD-16363, ... (7 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-4667

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-TABM-147, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-4922, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482

Genotype
studied in E-GEOD-17476, E-MEXP-421, E-TABM-321, E-TABM-868, E-GEOD-18005, ... (7 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-7011, E-MEXP-1446, E-GEOD-22278 ... (5 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-176, E-GEOD-1926, E-MEXP-1648, E-GEOD-19519, ... (24 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-GEOD-9723, E-GEOD-6927

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056, E-GEOD-12662

Ki67 ihc
studied in E-GEOD-21653

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-21750, E-GEOD-17636

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-19445, E-GEOD-19246

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-22541, E-GEOD-7307

Stimulation
studied in E-GEOD-20114

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Treatment
studied in E-GEOD-19246, E-GEOD-13818, E-GEOD-12198

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.535 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM